| Target Price | HK$6.83 |
| Price | HK$5.14 |
| Potential |
32.96%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Country Garden Services 2027 .
The average Country Garden Services target price is HK$6.83.
This is
32.96%
register free of charge
HK$9.09
76.91%
register free of charge
HK$6.46
25.76%
register free of charge
|
|
| A rating was issued by 19 analysts: 12 Analysts recommend Country Garden Services to buy, 6 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Country Garden Services stock has an average upside potential 2027 of
32.96%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 56.49 | 60.96 |
| 9.91% | 7.90% | |
| EBITDA Margin | 4.60% | 7.43% |
| 45.02% | 61.35% | |
| Net Margin | 1.24% | 4.67% |
| 69.74% | 275.41% |
15 Analysts have issued a sales forecast Country Garden Services 2026 . The average Country Garden Services sales estimate is
This results in the following potential growth metrics:
13 Country Garden Services Analysts have issued a net profit forecast 2026. The average Country Garden Services net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 0.21 | 0.87 |
| 66.67% | 314.29% | |
| P/E | 5.89 | |
| EV/Sales | 0.05 |
13 Analysts have issued a Country Garden Services forecast for earnings per share. The average Country Garden Services EPS is
This results in the following potential growth metrics and future valuations:
Country Garden Services...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


